Treatment of CMV infection in renal transplant recipients with an abbreviated course of IV ganciclovir.

被引:0
|
作者
Slavcheva, E
Jaffers, G
Narayanan, M
Moore, C
McCuskey, C
Carpenter, J
机构
[1] Scott & White Mem Hosp & Clin, TAMU, Temple, TX 76508 USA
[2] Scott & White Mem Hosp & Clin, Div Nephrol, Temple, TX 76508 USA
来源
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2002年 / 13卷
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:564A / 564A
页数:1
相关论文
共 50 条
  • [21] Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection
    Tornatore, KM
    Garey, KW
    Saigal, N
    Reed, K
    Murray, B
    Ingalls, E
    DiFrancesco, R
    Forrest, A
    Morse, G
    Venuto, R
    CLINICAL TRANSPLANTATION, 2001, 15 (05) : 297 - 308
  • [22] Preemptive treatment of CMV infection after liver transplantation (LT) using oral ganciclovir. Preliminary results.
    Duvoux, D
    ChallineLehmann, D
    Pawlotsky, JM
    Metreau, JM
    Cherqui, D
    Duval, J
    Dhumeaux, D
    HEPATOLOGY, 1997, 26 (04) : 117 - 117
  • [23] The Detection of CMV in Saliva Can Mark a Systemic Infection with CMV in Renal Transplant Recipients
    Waters, Shelley
    Lee, Silvia
    Lloyd, Megan
    Irish, Ashley
    Price, Patricia
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (20)
  • [24] Utility of "High-Dose" Ganciclovir in High Viral Load CMV Infection in Transplant Recipients
    Alfares, M.
    Avery, R.
    Turki, N.
    Alfares, K.
    Mehta, S.
    Boger, R.
    Valsamakis, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 502 - 502
  • [25] Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir
    Palmer, SM
    Grinnan, DC
    Reams, BD
    Steele, MP
    Messier, RH
    Davis, RD
    CLINICAL TRANSPLANTATION, 2004, 18 (02) : 179 - 185
  • [26] Ganciclovir (G) pharmacokinetics in renal transplant patients (RTR) with cytomegalovirus (CMV) infection.
    Saigal, N
    Venuto, R
    Tornatore, K
    Garey, K
    Murray, B
    Forrest, A
    Ingalls, E
    DiFrancesco, R
    Reed, K
    Morse, G
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1997, 8 : A3263 - A3263
  • [27] EFFECTS OF CYTOMEGALOVIRUS (CMV) INFECTION IN YOUNG RENAL-TRANSPLANT RECIPIENTS
    MARKER, SC
    HOWARD, RJ
    SIMMONS, RL
    SIEKERT, RG
    CONNELLY, DP
    NAJARIAN, JS
    BALFOUR, HH
    PEDIATRIC RESEARCH, 1979, 13 (04) : 464 - 464
  • [28] GANCICLOVIR THERAPY OF SYMPTOMATIC CYTOMEGALOVIRUS-INFECTION IN RENAL-TRANSPLANT RECIPIENTS
    GUERIN, C
    POZZETTO, B
    BROYET, C
    GAUDIN, O
    BERTHOUX, F
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1989, 4 (10) : 906 - 910
  • [29] Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients
    Israni, A
    Krok, K
    Cohen, D
    Blumberg, E
    Bloom, RD
    TRANSPLANTATION PROCEEDINGS, 2004, 36 (10) : 3019 - 3024
  • [30] Ganciclovir prophylasis and β-herpesvirus in renal transplant recipients
    Galarraga, MC
    Gómez, E
    Oña, M
    Rodríguez, A
    Laures, A
    Boga, JA
    Fernández, JA
    Melón, S
    TRANSPLANT INTERNATIONAL, 2005, 18 (08) : 1016 - 1017